Jill Spoerke
Overview
Explore the profile of Jill Spoerke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu S, Chang C, Guan Y, Szafer-Glusman E, Punnoose E, Do A, et al.
J Mol Diagn
. 2020 Apr;
22(6):770-781.
PMID: 32247862
Circulating tumor cells (CTCs) have a great potential for noninvasive diagnosis and real-time monitoring of cancer. A comprehensive evaluation of four whole genome amplification (WGA)/next-generation sequencing workflows for genomic analysis...
2.
Patel R, Tsan A, Tam R, Desai R, Spoerke J, Schoenbrunner N, et al.
PLoS One
. 2013 Jan;
7(12):e51153.
PMID: 23284662
Targeted anticancer therapies rely on the identification of patient subgroups most likely to respond to treatment. Predictive biomarkers play a key role in patient selection, while diagnostic and prognostic biomarkers...
3.
Stinson S, Lackner M, Adai A, Yu N, Kim H, OBrien C, et al.
Sci Signal
. 2011 Aug;
4(186):pt5.
PMID: 21868360
Compared with the luminal subtype, the basal-like subtype of breast cancer has an aggressive clinical behavior, but the reasons for this difference between the two subtypes are poorly understood. We...
4.
Stinson S, Lackner M, Adai A, Yu N, Kim H, OBrien C, et al.
Sci Signal
. 2011 Jun;
4(177):ra41.
PMID: 21673316
The basal-like subtype of breast cancer has an aggressive clinical behavior compared to that of the luminal subtype. We identified the microRNAs (miRNAs) miR-221 and miR-222 (miR-221/222) as basal-like subtype-specific...
5.
Boyd Z, Wu Q, OBrien C, Spoerke J, Savage H, Fielder P, et al.
Mol Cancer Ther
. 2008 Dec;
7(12):3695-706.
PMID: 19056674
Although breast cancer molecular subtypes have been extensively defined by means of gene expression profiling over the past decade, little is known, at the proteomic level, as to how signaling...